Guerbet Gets FDA Approval for U.S. Dotarem Production

22.04.2020 16:45

April 21, 2020 - Guerbet announced that it received U.S Food and Drug Administration (FDA) approval to manufacture Dotarem (gadoterate meglumine) injection at its Raleigh, N.C., facility. Until late 2019, Dotarem was manufactured exclusively outside of the United States. Read the complete news release here